Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase II Randomised Controlled Trial of Adjuvant Tumour-Infiltrating Lymphocytes for Pretreatment Epstein-Barr Virus DNA-selected High-Risk Nasopharyngeal Carcinoma Patients.

EUROPEAN JOURNAL OF CANCER(2023)

Cited 5|Views51
Key words
Adoptive immunotherapy,Tumour-infiltrating lymphocytes,Epstein-Barr Virus DNA,High-risk,Nasopharyngeal carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined